US › Healthcare

OrganiGram Holdings Inc (OGI)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.93-0.54%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$105.8M

Revenue YoY

+49.4%

Net profit

$105.5M

EPS

$-0.05

EPS estimate

$-0.01

Net margin

99.8%

EPS came in at -0.05 against a street estimate of -0.01 — a miss of 400.0%.

Key statistics

Market cap

$130.3M

P/E

2.1

Forward P/E

15.7

P/B

0.47

Book value

$2.42

EPS (TTM)

$0.43

52-week high

$2.24

52-week low

$0.85

50-day MA

$1.10

200-day MA

$1.25

Beta

1.91

Analyst view

Analysts rate OrganiGram Holdings Inc a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $8.80.

Shareholding

Insiders

31.06%

Institutions

6.54%

Largest institutional holders

Fund	Stake
Tidal Investments LLC.	1.50%
Renaissance Technologies Corp	1.00%
AdvisorShares Investments, LLC	0.62%
The Goldman Sachs Group Inc	0.40%
Morgan Stanley - Brokerage Accounts	0.25%
Baader Bank INC	0.17%
Bank of Montreal	0.17%
BMO Capital Markets Corp.	0.17%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for OrganiGram Holdings Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.